Prevalence of EED and Quality of Life Evaluated by Gastroesophageal Reflux Disease (GERD)-Q in Korean GERD Patients (Preedom)

AstraZeneca

Status: Completed

Conditions: Gastroesophageal Reflux Disease

Study type: Observational

Funder types: Industry

Identifiers

NCT00768196

NIS-GKR-DUM-2008/1

Details and patient eligibility

About

The purpose of this study is to asses the EED symptom prevalence in Koran GERD patients with typical reflux symptom and to evaluate quality of life with the scales including Gerd Q.

Enrollment: 2,000 estimated patients

Sex: All

Ages: 20 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• GERD patients who have experienced heartburn or acid regurgitation during past 7 days
• GERD patients who have already undergone endoscopy before enrolment

Exclusion criteria

• Involvement in the planning and conduct of the programme
• The person who took the medicine such as PPI or H2RA during the last 7 days
• Severe systemic disease